Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes-Reference-Cited by-同舟云学术

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes

Published:2021-07 Issue: Volume:Volume 13 Page:5941-5955
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Dellis Athanasios,Zakopoulou Roubini,Kougioumtzopoulou Andromahi^ORCID,Tzannis Kimon,Koutsoukos Konstantinos,Fragkoulis Charalampos,Kostouros Efthymios,Papatsoris Athanasios,Varkarakis Ioannis,Stravodimos Konstantinos,Boutati Eleni,Pagoni Stamata,Seferlis Miltiadis,Chrisofos Michael,Kouloulias Vasilios,Ntoumas Konstantinos,Deliveliotis Charalambos,Constantinides Constantine,Dimopoulos Meletios A,Bamias Aristotelis^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference41 articles.

1. Key Statistics for Bladder Cancer. Available from: https://www.cancer.org/cancer/bladder-cancer/about/key-statistics.html. Accessed July 21, 2018.

2. Witjes JA, Bruins HM, Cathomas R, et al. EAU Guidelines on Muscle-invasive and metastatic bladder cancer 2020. Available from: https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic. Accessed July 22, 2021.

3. Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG)

4. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

5. International Collaboration of trialists. Neoadjuvant methotrexate, vinblastine, and cisplatin chemotherapy for muscle-invasive bladder cancer: a randomized controlled trial. Lancet. 1999;354:533–540.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI;Contrast Media & Molecular Imaging;2022-08-04